Hemoglobin disorders: a look to the future
- PMID: 23929837
- DOI: 10.1182/blood-2013-06-506154
Hemoglobin disorders: a look to the future
Abstract
In this issue of Blood, Locatelli et al compare the results of histocompatible family donor bone marrow and cord blood transplants (BMT and CBT) for severe β thalassemia (SBT) and sickle cell disease (SCD) as experienced by the Eurocord and European Blood and Marrow Transplantation group and collaborating centers in the United States, Hong Kong, and Israel between 1994 and 2005. Obviously, many changes in medical care and particularly MHC typing occurred over that decade, so this retrospective represents a moving target, but some firm points can be made for which we are indebted to this excellent group.
Comment on
-
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.Blood. 2013 Aug 8;122(6):1072-8. doi: 10.1182/blood-2013-03-489112. Epub 2013 May 21. Blood. 2013. PMID: 23692854
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials

